XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Investments and fair value measurements (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Investments on Condensed Consolidated Balance Sheets
The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands):

As of June 30, 2023
Level 1Level 2Level 3
Cash equivalents:
Money market funds$281,719 $— $— 
Marketable securities:
U.S. government securities$— $142,287 $— 
Non-current assets:
Strategic investments$— $— $10,311 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $30 

As of December 31, 2022
Level 1Level 2Level 3
Cash equivalents:
Money market funds$130,377 $— $— 
U.S. government securities— 48,900 — 
Total cash equivalents$130,377 $48,900 $— 
Marketable securities:
U.S. government securities$— $151,687 $— 
Non-current assets:
Strategic investments$— $— $12,104 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $462 
Summary of Investments on Condensed Consolidated Balance Sheets
The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands):

As of June 30, 2023
Level 1Level 2Level 3
Cash equivalents:
Money market funds$281,719 $— $— 
Marketable securities:
U.S. government securities$— $142,287 $— 
Non-current assets:
Strategic investments$— $— $10,311 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $30 

As of December 31, 2022
Level 1Level 2Level 3
Cash equivalents:
Money market funds$130,377 $— $— 
U.S. government securities— 48,900 — 
Total cash equivalents$130,377 $48,900 $— 
Marketable securities:
U.S. government securities$— $151,687 $— 
Non-current assets:
Strategic investments$— $— $12,104 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $462 
Summary of the Changes in the Fair Value of Level 3 Financial Instruments
A summary of the changes in the fair value of Level 3 financial instruments, of which remeasurement of SARs and impairment of strategic investments are recognized in the condensed consolidated statements of operations, is as follows (in thousands):

Stock Appreciation RightsStrategic Investments
Balance— March 31, 2023
$264 $12,104 
Vesting and remeasurement of SARs19 — 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— June 30, 2023
$30 $10,311 
Balance— March 31, 2022
$508 $15,000 
Vesting and remeasurement of SARs, net(89)— 
Balance— June 30, 2022
$419 $15,000 
Balance— December 31, 2022
$462 $12,104 
Vesting and remeasurement of SARs(179)— 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— June 30, 2023
$30 $10,311 
Balance— December 31, 2021
$818 $10,000 
Vesting and remeasurement of SARs, net(399)— 
Purchases of strategic investments— 5,000 
Balance— June 30, 2022
$419 $15,000 
Summary of the Changes in the Fair Value of Level 3 Financial Instruments
A summary of the changes in the fair value of Level 3 financial instruments, of which remeasurement of SARs and impairment of strategic investments are recognized in the condensed consolidated statements of operations, is as follows (in thousands):

Stock Appreciation RightsStrategic Investments
Balance— March 31, 2023
$264 $12,104 
Vesting and remeasurement of SARs19 — 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— June 30, 2023
$30 $10,311 
Balance— March 31, 2022
$508 $15,000 
Vesting and remeasurement of SARs, net(89)— 
Balance— June 30, 2022
$419 $15,000 
Balance— December 31, 2022
$462 $12,104 
Vesting and remeasurement of SARs(179)— 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— June 30, 2023
$30 $10,311 
Balance— December 31, 2021
$818 $10,000 
Vesting and remeasurement of SARs, net(399)— 
Purchases of strategic investments— 5,000 
Balance— June 30, 2022
$419 $15,000